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Abstract
Alterations of the glucocorticoid system and of hippocampal volumes have consistently been reported in patients with major depressive disorders (MDD).
The aim of the present study was to investigate whether the messenger RNA (mRNA) expression of glucocorticoid inducible genes is associated with changes
in the cornu ammonis (CA) and dentate gyrus subfields. Forty-three patients with MDD and 43 healthy controls were recruited and investigated with high
resolution magnetic resonance imaging. Hippocampal subfields were measured using freesurfer. Measurement of whole blood mRNA expression of
glucocorticoid inducible genes serum and glucocorticoid-regulated kinase 1 (SGK1), FK506 binding protein 5 (FKBP5), and glucocorticoid induced
leucine zipper (GILZ) was performed. Patients with MDD had significantly smaller volumes of CA1, CA2/3, CA4/DG, and subiculum compared to healthy
controls. In the regression analysis, the factor diagnosis had a significant moderating effect on the association of SGK1 and hippocampal volumes. Patients with
low expression of SGK1 had significantly smaller CA2/3 and CA4/DG volumes compared to patients with high expression of SGK1 mRNA and to
healthy controls with low/high expression of SGK1, respectively. Therefore, a lack of mRNA expression of glucocorticoid inducible genes in patients
with MDD that seems to correspond to a blunted cortisol response is associated with smaller hippocampal CA and dentate gyrus volumes. SGK1 seems to
be particularly relevant for stress-related mental disorders.
Major depressive disorder (MDD) is among the most preva-
lent and burdensome of all psychiatric illnesses (Goetzel,
Hawkins, Ozminkowski, & Wang, 2003; Murray & Lopez,
1996). Evidence has suggested that aberrant neuronal plastic-
ity or neural remodeling play a significant role in the patho-
physiology of MDD. Recent experimental studies reveal
that certain aspects of depression result from maladaptive,
stress-induced neuroplastic changes in specific neural circuits
(Krishnan & Nestler, 2008). Stress, including psychological,
emotional, or psychosocial stress, is associated with structural
changes to the hippocampus (Chaney et al., 2014; Frodl &
O’Keane, 2013). Multiple studies have demonstrated that pa-
tients with MDD hypersecrete cortisol (Vreeburg et al.,
2009), have impaired glucocorticoid receptor (GR) function-
ing (Pace & Miller, 2009), and have reduced hippocampal
volumes (MacQueen & Frodl, 2011).
In cases when stress hits the individual in sensitive devel-
opmental time windows it may have enduring effects on the
neural and neuroendocrine systems (Danese & McEwen,
2012). This is understandable because the human brain shows
significant age-related changes at least until young adulthood
(Giedd & Rapoport, 2010). Thus, the time when stress occurs
in addition to the duration and severity of stress might be very
important. Early stress seems to result in overactivity of the
stress hormone system, but later due to ongoing stress the cor-
tisol response diminishes and results in blunted responses
(Frodl & O’Keane, 2013; Trickett, Noll, Susman, Shenk, &
Putnam, 2010).
In humans early life adversity was found to be associated
with both hypothalamus–adrenal–pituitary (HPA) axis ab-
normalities as well as with hippocampal volume changes
(Frodl & O’Keane, 2013). Chronic stress was found to be
associated with smaller cortisol response to the dexametha-
sone suppression test, suggesting the development of gluco-
corticoid resistance (Heim, Newport, Mletzko, Miller, &
Nemeroff, 2008; Raison & Miller, 2003). In the hippocam-
pus, chronic stress exposure causes a plastic remodeling
with volumetric reductions of the hippocampus (Sapolsky,
Krey, & McEwen, 1986).
Understanding the development of these hippocampal and
HPA axis abnormalities is important. An integrative attempt
is necessary and needs to incorporate multiple levels of anal-
ysis of intermediate phenotypes. Then it might be possible to
investigate disorders in a more dynamic fashion that reflects
social, environmental, genetic, and neurobiological aspects
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(Cicchetti & Toth, 2009). The first steps of a systemic neuro-
sciences approach are to integrate brain imaging and molecu-
lar methods in order to understand the functional interplay be-
tween systems.
An association between higher cortisol levels and smaller
hippocampal volumes has been supported from studies in
healthy controls and samples with psychiatric disorders with
a continuous measure of the cortisol levels over 1 day, rather
than measures taken at one time of the day only (Frodl &
O’Keane, 2013). Only one study in MDD investigated the as-
sociation between 24-hr urinary cortisol and the hippocam-
pus; it failed to find a significant result in the patient’s group,
but it was seen in the healthy comparison group (Vythilingam
et al., 2004). Although some studies with smaller sample sizes
of between 20 to 40 patients did not show such an association
between cortisol measures post-dexamethasone (DST) and
the hippocampal volume (Frodl & O’Keane, 2013), a study
in a larger sample of patients with arteriosclerosis detected as-
sociations between hippocampal volume and DST cortisol
(Knoops, Gerritsen, van der Graaf, Mali, & Geerlings, 2010).
Nearly all of these studies measured the whole hippocam-
pal volume. However, hippocampal cell layers are precisely
arranged in subfields of gyrus dentates and cornu ammonis
(CA1–3; Jones & McHugh, 2011). These hippocampal sub-
regions, like the dentate gyrus (DG) and the CA, have differ-
ent functions and seem to have different stress sensitivities.
Stress has been found to suppress neurogenesis and cause
atrophy of the CA subfields in animal studies (McEwen &
Magarinos, 2001), which are mostly present in hippocampal
head and tail. In line with this, we recently found that child-
hood maltreatment was associated with smaller hippocampal
head volumes in subjects at risk forMDD (Carballedo, 2012).
Moreover, smaller volumes in the CA2/3-DG subfield of the
hippocampus were linked to depressive symptoms and were
associated with hyperreactivity of cortisol secretion during
the day in multiple sclerosis patients (Gold et al., 2010), sug-
gesting region-specific effects of stress and daily cortisol
levels at least in subjects vulnerable for depression. In a study
exploring hippocampal subfield volumes with high resolu-
tion magnetic resonance imaging (MRI), 9 unmedicated pa-
tients with MDD had lower DG volumes than 27 control sub-
jects or 11 medicated patients with MDD and lower CA1–3
volumes than 27 control subjects (Huang et al., 2013).
There is thus a rationale for selectively exploring these sub-
fields. Moreover, it might be interesting to simultaneously ex-
amine measures of cortisol functioning that might be linked to
brain changes. In this context, the glucocorticoid inducible
genes, such as the glucocorticoid inducible leucin zipper
(GILZ), serum and glucocorticoid-inducible kinase-1 (SGK1),
and FK506 binding protein 5 (FKBP5), are target genes acti-
vated by GR activation; their expression has been shown to be
disrupted in the hippocampus as a result of hypercortisolemia
(Sarabdjitsingh et al., 2010). A previous study on messenger
RNA (mRNA) expression of SGK1 found that SGK1
mRNA is increased in the peripheral blood of drug-free
depressed patients and in the hippocampus of rats after
unpredictable chronic mild stress and prenatal stress. The
GR target gene, SGK1, mediates the cortisol-induced decrease
in proliferation and neuronal differentiation of human hippo-
campal progenitor cells, by acting both downstream of and up-
stream of GR activation (Anacker et al., 2013). A recent study
demonstrated a relationship between downregulation of GILZ
and an enhanced inflammatory profile in microglia isolated
from mice subjected to a chronic stress regimen (Wohleb
et al., 2011). Single nucleotide polymorphisms in FKBP5
were found to be associated with response to antidepressants
and the recurrence of depressive episodes (Binder et al.,
2004). In a previous study on the sample under investigation,
we had shown that patients with MDD, who had less expres-
sion of the glucocorticoid-inducible genesGILZ or SGK1 had
smaller total hippocampal volumes (Frodl et al., 2012).
The goal of this study was to extend this previous finding
and to investigate whether there is a significant association
among glucocorticoid inducible genes SGK1, GILZ, and
FKBP5 and hippocampal subfield volumes. As mentioned
above, SGK1,GILZ, and FKBP5were hypothesized from ex-
perimental studies to play a role for MDD. Moreover, an aim
was to explore whether these associations are specific to the
CA subfields that were found to be influenced by experi-
mental stress in previous studies. Another aim was to confirm
in a larger sample changes in the hippocampal subfields DG
and CA, in particular, region CA3 in patients withMDD com-
pared to healthy controls.
Methods
Participants
The study included 43 adult patients with MDD from the
mental health services of the Adelaide and Meath Hospital,
incorporating the National Children’s Hospital, Dublin, or
St. James’s Hospital, Dublin. The diagnosis of these patients
with MDDwas a clinical diagnosis based on DSM-IV criteria
and confirmed by an independent psychiatrist using the Struc-
tured Clinical Interview for DSM Disorders. Forty-three
healthy subjects (HC) from the local community were re-
cruited, and the groups were balanced for age and gender
(Table 1). Patients were prescribed monotherapy with antide-
pressants. Treatment with antipsychotics or mood stabilizers
were exclusion criteria. Other exclusion criteria were ages of
,18 or.65 years, a history of neurological or comorbid psy-
chiatric disorders (Axis I or Axis II), other severe medical ill-
ness, or head injury or severe substance abuse in their lifetime
history. Demographic variables, as well as inclusion and ex-
clusion criteria, were documented using a standardized ques-
tionnaire and through a structured interview by a psychiatrist.
Written informed consent was obtained from all partici-
pants after being given detailed description of the study,
which was designed and performed in accordance with the
ethical standards laid out by the Declaration of Helsinki
and was approved by the Research Ethics Committee of
St. James and the Adelaide and Meath Hospitals, Dublin.
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Rating instruments
Self- and observer-rated scales were also filled out for all par-
ticipants included in the study. The rating scales that were
used were the following: the Childhood Trauma Question-
naire (CTQ) is a standardized self-report instrument that as-
sesses five types of childhood trauma; the Hamilton Rating
Scale for Depression (Hamilton, 1969) is an observer-rating
instrument to assess current depression severity; the Beck’s
Depression Inventory (Beck, Steer, Ball, & Ranieri, 1996)
is a self-rating instrument to indicate depression severity;
and the Structured Clinical Interview for DSM-IV personality
questionnaire (Spitzer, Williams, Gibbon, & First, 1992) is a
self-rating and observer-rating instrument to assess personal-
ity disorders. Specifically, the CTQ (Bernstein et al., 1994)
was used to assess childhood maltreatment: emotional, phys-
ical, and sexual abuse, and emotional and physical neglect.
Reliability and validity of the CTQ have been established, in-
cluding measures of convergent and discriminative validity
from structured interviews, stability over time, and corrobora-
tion (Bernstein et al., 2003). Based on this previous research,
a threshold was used in order to categorize adversity when a
participant had scores greater than the cutoff score in at least
one of the subscales of physical abuse (10) and/or emotional
abuse (12) and/or sexual abuse (8) and/or emotional
neglect (15) and/or physical neglect (10).
MRI data acquisition
Magnetic resonance images were obtained with a Philips
Achieva MRI scanner (Philips Medical System, Netherland
B.V., Best, The Netherlands) operating at 3 Tesla. A sagittal
Time 1 three-dimensional turbo field echo was used to
scan all participants (repetition time user defined at 8.5 ms;
echo time user defined at 3.9 ms; total acquisition time of
7 min; field of view of foot to head, 256 mm; anterior to
posterior, 256 mm; right to left, 160 mm; 256  256
matrix). The slice thickness was 1 mm, and the voxel size
was 111 mm.
Definition of hippocampus
Hippocampal subfield volumes were assessed fully automat-
ically with the software FreeSurfer. Freesurfer uses a Bayes-
ian modeling approach, in which an explicit computational
model of an MRI image around the hippocampal area is
generated, and subsequently this model is used to obtain au-
tomated segmentations for the hippocampal subfields. The al-
gorithm uses models built from manual segmentations of the
hippocampus and applies these to the MRI data (http://surfer.
nmr.mgh.harvard.edu/fswiki/HippocampalSubfieldSegmen
tation). The original development of this algorithm and de-
tailed description can be found in Van Leemput et al. (2009).
Here we use the main hippocampal subfields belonging to
the CA and the DG (CA1, CA2/3, and CA4/DG), as well as
the subiculum and presubiculum (Figure 1). Manual quality
control was done on each subject to ensure that the automated
routines captured the hippocampus adequately. Moreover,
data were checked for outliers using boxplots and histograms.
It was shown that automatically calculated volumes of
CA2/3 and CA4/DG are strongly correlated with those vol-
umes derived from manual delineation, with correlation coef-
ficients of .91 (P  .0002) and .83 (P  .0028), respectively.
Thus, the reliability of the subiculum (r ¼ .66, p ¼ .06) was
weaker and that of the presubiculum was not significant (Van
Leemput et al., 2009). Total intracranial volume was also
measured using Freesurfer.
Measurement of expression of GR and glucocorticoid-
inducible genes
Blood sampling. A blood sample (2.5 ml) was drawn into a
PAXgene blood RNA tube (Qiagen UK) and used for whole
blood RNA isolation. The PAXgene tube was stored at –80
8C until RNA extraction was performed.
Real-time polymerase chain reaction (PCR) analysis of
mRNA expression of FKBP5, GILZ, and SGK1 in whole
blood samples. RNA isolation was performed using a
Table 1. Demographic and clinical data
Patients
(N ¼ 43)
Controls
(N ¼ 43) df
Diagnosis
Effect
Age 41.2 (10.2) 37.3 (13.0) 84 T ¼ 1.6, p ¼ .12
Sex, female/male 26/17 26/17 84 x ¼ 0.17, p ¼ .68
Height 171.3 (8.4) 171.9 (10.4) 84 T¼ –0.27, p¼ .78
Weight 74.8 (15.1) 70.4 (16.2) 84 T ¼ 1.3, p ¼ .19
Medication (none/SSRI/dual acting AD) 12/15/16
Age of onset 25.9 (12.4)
Cumulative illness duration 9.1 (9.9)
Days treated 2268.5 (3285.8)
Days depressed and not treated 1426.1 (2576.1)
Hamilton depression score 28.9 (5.9) 2.3 (2.2) 84 T¼ 27.7, p, .001
Beck Depression 33.0 (11.1) 1.9 (2.3) 84 T¼ 18.0, p, .001
Note: SSRI, Selective serotonin reuptake inhibitor; AD, antidepressant.
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PAXgene blood RNA kit (Qiagen) and was followed by
DNAase treatment to remove contaminating genomic DNA
as previously described (Chai, Vassilakos, Lee, Wright, &
Young, 2005). Following RNA quantification and equaliza-
tion, complementary DNAwas synthesized using a cDNA ar-
chive kit (Applied Biosystems UK). Gene expression analysis
was conducted using real-time PCRemploying TaqmanwGene
Expression Assays (assay IDs: FKBP5, Hs01561006_m1;
GILZ, Hs00608272_m1; SGK1, Hs00178612_m1; Applied
Biosystems UK), and GAPDH served as endogenous control.
PCR was performed using ABI’s universal cycling conditions
on the StepOnePlusTM Real-Time PCR system.
Statistics
All statistical analysis were considered to be significant if p,
.05. Differences in demographic variables were tested using
the Student t test, the chi-square test for gender distribution,
and the Mann–Whitney U test for differences in nonparamet-
ric clinical variables. Morphometric measurements in both
groups were normally distributed (using the Kolmogorov–
Smirnov test), and their variances were homogenous (using
the Levene test).
The mRNA expressions of glucocorticoid-inducible genes
were subjected to an analysis of covariance in order to ana-
lyze main effects of diagnostic group (MDD, HC), gender
(female, male), and childhood adversity (yes, no) using age
as a covariate. Multiple regression analyses were carried
out to analyze the association between the independent fac-
tors diagnostic group (MDD, HC), gender (male, female),
childhood adversity, age, total intracranial volumes, and
mRNA expression of SGK1 (GILZ, FKBP5, respectively)
on hippocampal volumes. Because there were three subse-
quent analyses carried out, we also considered multiple test-
ing and indicate where results survive Bonferroni correction
with a threshold of 0.05/3 ¼ 0.017. This analysis was also
performed for subfield volumes CA1, CA2–3, DG, subicu-
lum, and presubiculum. Thus, we performed five subse-
quent analyses on hippocampal subfields, which however
are correlated to each other. Statistical correction for multi-
ple testing was therefore done with a false discovery rate
(FDR).
Moreover, stratifying patients and controls by SGK1 (high/
low expression based on the median) resulted in four groups:
analysis of variancewith hippocampal subfields as dependent
variable and group as factor was carried out also applying
FDR correction. This was followed by Dunnett-T3 post hoc
subgroup comparisons assuming different variances between
groups.
Results
With regard to mRNA expression of SGK1,GILZ, or FKBP5,
no significant main effect of diagnostic group, childhood
Figure 1. (Color online) Example for hippocampal subfield delineation. Shown are cornu ammonis (CA) subfields CA1, CA2/3, CA4/dentate
gyrus (DG), subiculum, and presubiculum. The program Freesurfer automatically assessed volumes of subfields, which are thenmanually viewed
and checked for quality.
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adversity, or sex was detected, and no significant interaction
between these factors was observed.
A diagnosis of MDD was associated with smaller hippo-
campal volumes. Age, gender, mRNA expression of SGK1,
and childhood adversity were not significantly associated.
Moreover, the regression analysis showed that diagnosis
had a moderating effect on the association of SGK1 and hip-
pocampal volumes (Table 2). These results survived Bonfer-
roni correction for SGK1 when considering that GILZ and
FKBP5 were also analyzed. The association between mRNA
expression of SGK1 and hippocampal volumes was seen in pa-
tients with MDD (Figure 2).
In regard to the hippocampal subfields, these effects were
most significant for CA2/3, overall effect: F (6/79) ¼ 11.8,
p , .001, pFDR , .005; diagnosis effect: p ¼ .002, pFDR ¼
.01; DiagnosisSGK1 interaction: p ¼ .015, pFDR ¼ .08; and
CA4/DG, overall effect: F (6/79) ¼ 9.0, p , .001, pFDR ,
.005; diagnosis effect: p ¼ .006, pFDR ¼ .024; and Diagnosis
 SGK1 interaction: p ¼ .025, pFDR ¼ .10. The model for
CA1 was significant, F (6/79) ¼ 11.8, p , .001, pFDR ,
.005, with a trend toward significance for the factor diagnosis
( p¼ .027, pFDR ¼ .081), but no significant SGK1Diagnosis
interaction ( p ¼ .073, pFDR ¼ .22). Similarly, the subiculum
showed a trend toward a significant association of diagnosis, p
¼ .043, pFDR ¼ .086; overall model: F (6/79) ¼ 9.6, p ,
.001, pFDR , .005, but no interaction between diagnosis and
SGK1. For the presubiculum, no significant diagnosis or Diag-
nosisSGK1 interactionwas detected. Significant diagnosis ef-
fects are presented in Figure 3.
The results of the regression analysis were similar, but not
as strong, when using GILZ mRNA expression. Interactions
on an uncorrected level between diagnosis and GILZ mRNA
expression were found on CA2/3 (b ¼ 0.72, p ¼ .05, pFDR
¼ .20), on CA4/DG (b ¼ 0.77, p ¼ .048, pFDR ¼ .24), and
on subiculum (b¼ 0.73, p¼ .05, pFDR ¼ .15), but not on pre-
subiculum andCA1. However, these did not survive FDRcor-
Table 2. Parameters of the investigated regression model: gender, age, MDD diagnosis, childhood
trauma, mRNA expression of SGK1, the interaction term of SGK1×Diagnosis, and hippocampal
volume as outcome variable
Statistical
Model
Multiple
R
Overall
p
Stand.
Beta t
P Stand.
Beta
Predictors .51 .001
Gender 20.07 20.52 .61
Age 0.09 0.76 .44
MDD diagnosis 20.88 22.9 .005
Childhood trauma 20.06 20.51 .61
mRNA-SGK1 0.014 0.10 .92
ICV 0.35 2.7 .009
Diagnosis×mRNA-SGK1 0.75 2.43 .017
Note:MDD,Major depressive disorder; mRNA, messenger RNA; SGK1, serum and glucocorticoid-regulated kinase 1 gene; ICV, total
intracranial volume.
Figure 2. (Color online) Association between hippocampal volumes and
serum and glucocorticoid-regulated kinase 1 gene (SGK1). A significant pos-
itive correlation was observed between hippocampal volumes and SGK1 in
patients. Thus, patients with lowest SGK1 messenger RNA expression
were those with the smallest hippocampal volumes.
Figure 3. (Color online) Comparison of hippocampal subfields between pa-
tients and healthy controls. Cornu ammonis (CA) subfields CA1, CA2/3,
CA4/dentate gyrus (DG), and subiculum volumes are significantly smaller
in patients with major depressive disorder (MDD) compared to healthy con-
trols (HC). Bars above columns indicate standard deviations.
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rection. There were neither significant associations between
mRNA expression of FKBP5 and hippocampal volumes or
subfield volumes, nor any significant interaction between di-
agnosis and FKBP5 mRNA expression.
Stratifying patients and controls by mRNA expression
of SGK1 revealed significant analysis of variance effects
for CA1, (F 3/82) ¼ 3.6, p ¼ .017, pFDR ¼ .05; CA2/3
(F 3/82) ¼ 4.7, p ¼ .005, pFDR ¼ .025; CA4/DG (F 3/82)
¼ 3.9, p ¼ .012, pFDR ¼ .048; and subiculum, (F 3/82) ¼
3.6, p ¼ .018, pFDR ¼ .036. Post-hoc Dunnett T3 testing
for multiple subgroup comparisons found that patients with
low expression of SGK1 had significantly smaller volumes
of CA2/3 compared to patients with high SGK1 expression
(d ¼ 1242, p ¼ .05), HC with low SGK1 expression (d ¼
1901, p ¼ .013), and HC with high SGK1 expression (d ¼
1454, p ¼ .022; Figure 3). Patients with low expression of
SGK1 had significantly smaller volumes of CA4/DG com-
pared to HC with low SGK1 expression (d ¼ 940, p ¼
.029) and HC with high SGK1 expression (d ¼ 741, p ¼
.047), and showed a trend toward significance compared to
patients with high SGK1 expression (d¼ 659, p¼ .089). Pa-
tients with low expression of SGK1 had significantly smaller
volumes of CA1 compared to HC with low SGK1 expression
(d ¼ 555, p ¼ .013).
Unmedicated patients (N ¼ 12) with MDD did not differ
compared to medicated patients (N ¼ 31) with regard to
mRNA expression of glucocorticoid-inducible genes or hip-
pocampal subfield volumes.
Discussion
In the present study we confirmed that CA and DG volumes
are significantly smaller in patients with MDD compared to a
healthy control group. Smaller hippocampal volumes have
consistently been reported in patients with MDD compared
to healthy controls (Campbell, Marriott, Nahmias, & Mac-
Queen, 2004; Frodl et al., 2002; MacQueen & Frodl, 2011).
The results are also in line with the study from Huang et al.
(2013), who reported smaller DG and CA (CA1–3) volumes
in patients with MDD compared to control subjects. Reduced
hippocampal volume is not a specific finding in depression and
has been demonstrated in other psychiatric disorders. Hippo-
campal volume reductions can be seen in schizophrenia (Mei-
senzahl et al., 2010), in posttraumatic stress disorders (Schmahl
et al., 2009), and in preclinical stages of Alzheimer disease
(Hampel et al., 2008; Jack et al., 1999). Thus, finding novel
blood biomarkers with clinical relevance for diagnosis or ther-
apy prediction in psychiatric diseases that are associated with
hippocampal volume changes has wider implications than
just in the area of depression.
In a previous study on mRNA expression of SGK1, it was
found that SGK1 mRNA is increased in the peripheral blood
of drug-free depressed patients and in the hippocampus of rats
after unpredictable chronic mild stress and prenatal stress
(Anacker et al., 2013). In the present study, we did not find
any significant differences for the measured glucocorticoid-
inducible genes between patients with MDD and HC, and
there was no significant effect of childhood adversity. Explor-
ing whether medication could have an effect here, we demon-
strated that there was no difference between unmedicated pa-
tients and patients currently taking antidepressants.
Smaller CA and DG volumes in patients with MDD were
found in those patients who had reduced expression of SGK1
or GILZ mRNA, respectively, as a marker of reduced activa-
tion of the glucocorticoid system compared to those with
higher GILZ mRNA expression. In the patients, GILZ and
SGK1mRNAwas positively correlated with these hippocam-
pal subfield volumes, indicating that a subgroup of patients
with MDD showing both reduced mRNA expression of
glucocorticoid-inducible genes and reduced hippocampal
volumes exists. The GR target gene, SGK1, mediates the cor-
tisol-induced decrease in proliferation and neuronal differen-
tiation of human hippocampal progenitor cells, by acting both
downstream and upstream of GR activation (Anacker et al.,
2013), and thus might be involved in hippocampal neuroge-
nesis. An association between lower mRNA expression of
SGK1 or GILZ with smaller hippocampal volumes might be
contradictory to the idea that increased cortisol levels may
result in decreased hippocampal volumes. However, it has
to be taken into account that a blunted cortisol response
was found for patients with MDD (Suzuki, Belden, Spitzna-
gel, Dietrich, & Luby, 2013) as a sign of deregulation of the
HPA axis that might result in reduced expression of glucocor-
ticoid-inducible genes as well. There is some evidence that
stress early in life results in increased cortisol response at
the beginning but that later due to ongoing stress the cortisol
response diminishes and results in blunted responses (Frodl &
O’Keane, 2013; Trickett et al., 2010). At the same time, early
life stress is associated with reduced hippocampal volume de-
velopment (Frodl & O’Keane, 2013), and these parallel pro-
cesses might explain the association between reduced mRNA
expression of SGK1 and hippocampal volumes in the current
study.
No significant associations were detected between hippo-
campal subfields and mRNA expression of FKBP5. Although
mRNA expression and certain variants of a gene are not nec-
essarily associated, this lack of finding should be discussed
in terms of recent results about an association with genetic var-
iants. A previous study showed an effect of polymorphisms of
FKBP5 on posterior cingulum diffusivity that links the
hippocampus with cortical brain regions in a sample of 82
traumatized females. Compared with individuals without
this allele, individuals who carried two “risk” alleles for
this FKBP5 single nucleotide polymorphism demonstrated
significantly lower fractional anisotropy in the left posterior
cingulum, even after statistically controlling for variance as-
sociated with age, trauma exposure, and posttraumatic stress
disorder symptoms (Fani et al., 2013). Moreover, in a study
with 120 school children, the interaction of genetic profile
scores of FKBP5 and early life stress predicted left hippo-
campal and left amygdala volume changes (Pagliaccio
et al., 2013).
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The association between mRNA expression of SGK1 and
GILZ with hippocampal subfields were found to be strongest
in the DG, lower but still significant in the subfield CA2/3,
and lowest in the subfield CA1. Whether this might have to
do with the hippocampal information circuit among the en-
torhinal cortex, DG, and CA3 to CA1 regions can only be
speculative at this stage. These subfields may be involved dif-
ferently in encoding, consolidation, and recall (Jones &
McHugh, 2011). In addition, it is important here that
neurogenesis happens within the DG. Because the CA3 and
CA1 subfields were also found to be associated with
mRNA expression, this association is driven by at least addi-
tional factors other than neurogenesis. A limitation here
might be that these subfield measures were automatic mea-
sures oriented on the radiological information that may not
be in line with the exact histological determination of sub-
fields.
It is noteworthy that a recent study in mice showed that re-
peated social defeat stress reduced mRNA expression of the
glucocorticoid-responsive genes, including GILZ, in micro-
glia (Wohleb et al., 2011), indicating the involvement of
GILZ in stress-related diseases like depression or anxiety dis-
orders. Moreover, it has been suggested that glucocorticoid
resistance may contribute to the inflammatory profile ob-
served in MDD (Zunszain, Anacker, Cattaneo, Carvalho, &
Pariante, 2011). Nevertheless, the glucocorticoid system
plays a central role in the pathophysiology of MDD. There
is mounting evidence that specific neuronal circuits, particu-
larly in the developing brain, are damaged by environmental
stress inducing changes in the HPA axis and inflammatory
pathways (Krishnan & Nestler, 2008). Stress-related hyper-
cortisolemia leads to central downregulation of GRs (Krish-
nan & Nestler, 2010) and to glucorticoid resistance in periph-
eral immune cells (Zunszain et al., 2011).
There is much broader research on the association between
brain structure and the glucocorticoid system. The first study
that assessed the association between hippocampal volumes
and cortisol measures was published in 1998 by Lupien
et al. This longitudinal study conducted over 5 years in older
adults has demonstrated a correlation over time between cor-
tisol levels and hippocampal volume changes. The total hip-
pocampal volume of six subjects with increasing or high cor-
tisol levels was significantly reduced by 14% in comparison
to that of five subjects with decreasing/moderate cortisol
levels, and the degree of hippocampal atrophy correlated
strongly with both the degree of cortisol elevation over time
and current basal cortisol levels (Lupien et al., 1998).
Subsequent studies then used different measures of the
HPA axis including the DST, cortisol-awakening response,
stress tests, and basal as well as diurnal cortisol measures.
A review of this literature indicated that most consistent
associations were found between increased levels of cortisol
over the day and reduced hippocampal volumes. Just measur-
ing cortisol in the morning at awakening seems to not be a
stable index of cortisol functioning as linked to brain struc-
tures. However, the cortisol-awakening response with several
measures after awakening and cortisol responses after stress
tests might have a better potential to reflect the physiology
of the system, possibly reflecting that the hippocampus
might have some regulatory influences (Frodl & O’Keane,
2013).
It is important to note that there were some limitations
present in this study. As mentioned in the Methods Section,
the automatic delineation of the subiculum and presubiculum
was not found to be strongly in line with manual segmenta-
tions. Thus, the results about these two latter subfields and
in particular the lack of significant effects with regard to
the presubiculum have to be taken with caution. The signifi-
cant finding seen for the group differences in CA2/3 and DG
volumes might be promising that the automatic method is
valid and captures the hippocampal changes, becausewe con-
firmed the results from a previous manual tracing study. A
limitation might further be that two-thirds of our patients
were currently on antidepressant medication, and the other
third came to our service medication free and were scanned
before a treatment was initiated. However, the results did
not change when medication status was used as a covariate
in the analysis, and hippocampal volumes did not differ
between those with and without antidepressant medication.
The acute effect that antidepressants might have on brain
structure has not yet been shown consistently (Vermetten,
Vythilingham, Southwick, Charney, & Bremner, 2003; Vy-
thilingam et al., 2004), and this is a matter for future studies.
Interpretation of the findings would have been enhanced by
measures of cortisol output. To overcome the issue of multi-
ple testing, we used multiple regression analysis with FDR
and Bonferroni correction and omnibus analysis of covar-
iance designs with post hoc tests. In addition, the sample
size with 43 patients and 43 controls was reasonable for an
imaging study looking at objective correlations with blood
markers. For more in-depth interactive analyses among diag-
nostic groups, glucocorticoid profile, and childhood maltreat-
ment, a larger group size would have been preferable. From
the current cross-sectional research, it is not possible to con-
clude on the direction of effects betweenMDD,mRNAexpres-
sion of SGK1, and structural changes in brain. There seem to be
effects from both directions, because it is known from longitu-
dinal studies that structural changes may render subjects more
vulnerable to develop depression and that also a more severe
illness course results in structural volume declines (Frodl,
Jager, et al., 2008; Frodl, Koutsouleris, et al., 2008).
In summary, a reduced expression of glucocorticoid indu-
cible genes SGK1 andGILZwas associated with reduced hip-
pocampal subfield volumes, in particular CA2/3 and CA4/
DG in MDD. Thus SGK1 and GILZ seem to be particularly
relevant for stress-related mental disorders. These findings
might have potential for identifying blood biomarkers associ-
ated with hippocampal changes relevant for psychiatric dis-
eases. Messenger RNA expression of SGK1 from the periph-
eral blood system associated with hippocampal volumes thus
might include characteristic information of the glucocorticoid
system.Whether a blunted cortisol response or glucocorticoid
mRNA expression of SGK1 and hippocampal subfields 1215
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resistance might be indicated by reduced mRNA expression
of SGK1 and whether SGK1 represents trait characteristics
needs further investigation. Further studies also need to
explore the possible clinical usefulness of such a blood bio-
marker (e.g., for diagnosis or prediction of therapy response
or even for risk and resilience).
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